methyl N-acetylsibirosaminide: Clinical Trials

11 trials of methyl N-acetylsibirosaminide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 4 Not applicable, 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable4Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1
Phase 14Completed 2, Terminated 2
Phase 23Completed 2, Terminated 1

Follow methyl N-acetylsibirosaminide: new trials by email Literature Review of methyl N-acetylsibirosaminide trials Research Report on methyl N-acetylsibirosaminide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Non-standardized vs. Standardized Screening for Dysphagia
Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool), Non-standardized clinical swallow evaluation - Dysphagia
Not applicableRecruitingUniversity of Miami502024-04-052026-04-29
Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension
serum concentration of estrogen (E1 and E2) and testosterone ratio measurement - Hypotension, Cirrhosis
WithdrawnMethodist Health System2021-08-222026-03-24
The Use of High-energy Digestible Food in Women Undergoing Caesarean Section
high-energy digestible food E2, glucose injection G2, normal saline N2 - Caesarean Section
Not applicableUnknownShanghai First Maternity and Infant Hospital1402018-12-012018-11-20
QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer
ETBX-011, ALT-803 - Thyroid Cancer, Colon Cancer
Phase 1 / Phase 2TerminatedNantCell, Inc.32017-06-262024-08-06
QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer
ETBX-021 - Cancer
Phase 1TerminatedNantBioScience, Inc.32017-03-042025-01-13
A 3-Arm Study on G7 Acetabular Cup With Echo BiMetric Stem in Total Hip Arthroplasty
Hip Arthroplasty - Osteoarthrosis, Pain
Not applicableActive not recruitingZimmer Biomet3602015-05-042025-11-25
Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients
NRD135S.E1, Placebo to match NRD135S.E1 - Diabetic Peripheral Neuropathic Pain
Phase 2CompletedNovaremed Ltd.882015-04-012016-09-22
Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies
Determination of Anti-Rubella Antibody, E1 - Pregnancy
Not applicableCompletedHopital Foch1922012-02-012017-02-01
A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1
E1 and G1 - Type 2 Diabetes
Phase 1CompletedOPKO Health, Inc.302005-09-012019-10-18
A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1
E1 and G1 - Type 1 Diabetes
Phase 1CompletedOPKO Health, Inc.202005-06-012019-10-18
Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer
Alprostadil (E1), Papaverine, Phentolamine mesylate - Prostate Cancer
Phase 2CompletedM.D. Anderson Cancer Center1112001-08-012012-07-30

Conditions studied

Breast Neoplasms (2)  ·  Neoplasm Metastasis (2)  ·  Arthritis (1)  ·  Breast Neoplasms, Male (1)  ·  Colonic Neoplasms (1)  ·  Deglutition Disorders (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Fibrosis (1)  ·  Hypotension (1)  ·  Infertility (1)  ·  Lung Neoplasms (1)  ·  Measles (1)  ·  Neoplasms (1)  ·  Osteoarthritis (1)

Sponsors

OPKO Health, Inc. (2)  ·  Hopital Foch (1)  ·  M.D. Anderson Cancer Center (1)  ·  Methodist Health System (1)  ·  NantBioScience, Inc. (1)  ·  NantCell, Inc. (1)  ·  Novaremed Ltd. (1)  ·  Shanghai First Maternity and Infant Hospital (1)  ·  University of Miami (1)  ·  Zimmer Biomet (1)

Countries

United States (6)  ·  China (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Israel (1)  ·  Sweden (1)

Top investigators

Aleksandra Pastrak, M.D. (2)  ·  Anders Troelsen, MD, PhD (1)  ·  Christopher G. Wood, MD (1)  ·  Eli Kaplan, MD (1)  ·  Gemayaret Alvarez, MD (1)  ·  Henrik Malchau, MD, PhD (1)  ·  Mangesh Pagadala, MD (1)  ·  Olivier Picone (1)  ·  Ville Remes, MD, PhD (1)

Results publications

PMID 18783876

NIH funding

P30CA016672 (1), P50CA090270 (1)